The 2011 Leading Pharmaceutical Companies Collaborative Arrangements

October 2010 | 200 pages | ID: L732C318EB0EN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

For each company, the report analyzes:

• Major joint venture, distribution, OEM, and licensing partners, both industrial and academic.
• Terms of collaborative agreements and specific products involved.

The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 200 pages